Trazodone Hydrochloride
- Product NDC
- 55045-1715
- 11-digit product format
- 550451715
- Labeler code
- 55045
- Product ID
- 55045-1715_1531bc94-6955-4325-b76d-c8fbeeab70a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trazodone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dispensing Solutions, Inc.
- Application
- ANDA071523
- Marketing category
- ANDA
- Marketing start
- 2011-01-20
- Marketing end
- 0000-00-00
- Substance
- TRAZODONE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 55045-1715 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 55045-1715 | 55045-1715-8 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071523-001 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 1987-12-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A071523-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071523-001 | TRAZODONE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 1987-12-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071523-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Unit Dose Solutions, Inc. | 562fdfb9-c060-63bc-e063-6294a90ad840 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | 38e9820a-6edc-4bf5-b5e4-034b9e48b583 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 310c4b81-d2cf-4014-873d-e71d036105de | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | AvKARE | b3723265-7455-c25c-e053-2a95a90a379b | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Northwind Health Company, LLC | f2f2290f-b53c-3b38-e053-2995a90a157d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d42fd0c8-3673-4f18-a6c0-cd276bbf9fef | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ab590d8-225f-43f4-bb68-1f2c86f9a886 | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 4006d439-e2de-4590-82e9-fc9d56e3ec1b | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Proficient Rx LP | f6c3fb84-5b68-4675-a853-fe49bfbf3f9f | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 071523 ANDA071523 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac7a3d9b-58c0-4ffc-a3eb-ed863453525e | Product name | 1 | 20250730 |
| b2f15d64-48ea-ba98-af5c-91f410667b31 | Product name | 5 | 20250314 |
| d8e7f61b-4ab5-0dbe-2706-4e11b6079b87 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55045-1715-8 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c8cf-f6ea-e053-dbdaa90aa703 | TRAZODONE HYDROCHLORIDE TABLETS, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55045-1715-8 | Trazodone Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55045-1715-8 | EA - Each | 55045-1715 | 82c74461-7eb2-4fc9-bffb-96df451254cd | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TRAZODONE HYDROCHLORIDE | ACTIVE INGREDIENT | 6E8ZO8LRNM | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| TRAZODONE | ACTIVE MOIETY | YBK48BXK30 | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55045-1715 | TRAZODONE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | Legacy NDC, 1 package rows | 20111004_4005feb3-1349-4ca9-9a51-dc84426e4a55.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 856377 | traZODone HCl 50 MG Oral Tablet | PSN | 4005feb3-1349-4ca9-9a51-dc84426e4a55 | 2 |
| 856377 | trazodone hydrochloride 50 MG Oral Tablet | SCD | 4005feb3-1349-4ca9-9a51-dc84426e4a55 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 55045-1715-8 | 55045171508 | 30 in 1 BOTTLE | Historical |